Biotechnology - Puma Biotech, Oncology

Filter

Current filters:

Puma BiotechOncology

Popular Filters

Puma Biotech rockets on positive results with neratinib in I-SPY 2 TRIAL

06-12-2013

USA-based development-stage firm Puma Biotechnology saw its shares leap 42% to nearly $66 in morning…

BiotechnologyneratinibOncologyPfizerPuma BiotechResearch

Back to top